Navigation Links
Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Date:10/20/2011

tic Breast Cancer 27

Figure 33: Drug Model Diagram of Afinitor in the US, EU and Japan 33

Figure 34: Afinitor, Breast Cancer, Global, Sales Forecasts ($m), 2013–2020 35

Figure 35: Afinitor, Breast Cancer, the US, Sales Forecasts ($m), 2013–2020 36

Figure 36: Afinitor, Breast Cancer, the UK, Sales Forecasts ($m), 2013–2020 37

Figure 37: Afinitor, Breast Cancer, France, Sales Forecasts ($m), 2013–2020 38

Figure 38: Afinitor, Breast Cancer, Germany, Sales Forecasts ($m), 2013–2020 39

Figure 39: Afinitor, Breast Cancer, Italy, Sales Forecasts ($m), 2013–2020 40

Figure 40: Afinitor, Breast Cancer, Spain, Sales Forecasts ($m), 2013–2020 41

Figure 41: Afinitor, Breast Cancer, Japan, Sales Forecasts ($m), 2013-2020 42

Figure 42: Afinitor, Breast Cancer, Global, Sales Distribution by Country ($m), 2020 43

Figure 43: Drug Model Diagram 46

Figure 44: Patients Approved to take the Drug 47

To order this report:

Pathology Industry: Afinitor (Breast Cancer) – Analysis and Forecasts to 2020

Pathology Business News

More  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
3. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
4. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
7. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
8. FDA Approves New Indication for Afinitor
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
11. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... ATLANTA, April 7, 2011 Vystar® Corporation ... Natural Rubber Latex (NRL), a patented, all-natural raw ... other non-rubbers found in natural rubber latex, has ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney ...
... Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, ... of the Company,s therapeutic and preventative HIV vaccines at the ... Convention Center in Washington DC on Thursday, April 14.  Dr. ... a.m., will cover the topic of recombinant viruses as vaccines. ...
Cached Medicine Technology:Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
(Date:4/23/2014)... targets an important brain receptor has a dramatic effect ... behavior, a University at Buffalo animal study has found. ... be a novel lead compound for treating cocaine addiction, ... was published as an online preview article in ... compound, RO5263397, severely blunted a broad range of cocaine ...
(Date:4/23/2014)... science, "simple and accessible detection methods that can ... resolution of a single cell inside that population ... engineer Chang Lu. , In the Royal Society ... has announced that he and his coworkers have ... location of a protein ( Chem. Sci. , ...
(Date:4/23/2014)... - In a country as wealthy as the United States, ... seniors do not have access to adequate food due to ... insecure. , Recent research at the University of Illinois ... (NHANES) revealed that the seniors who are dealing with hunger ... "In 2011, 8.35 percent of Americans over age 60 faced ...
(Date:4/23/2014)... Effects of Midlife Occupational and Leisure Time Physical Activity ... physical activity in midlife increases the risk of mobility ... the risk. This is found in a study which ... The study was conducted at the Gerontology Research Center ... , Heavy physical labor is often repetitive, wears the ...
(Date:4/23/2014)... Getting to the bottom of Alzheimer,s disease has ... turns and controversies. In the latest crook in ... insight into the interaction between proteins associated with ... journal ACS Chemical Neuroscience , could have ... K. Surewicz, Krzysztof Nieznanski and colleagues explain that ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... , NASHVILLE, Tenn., July 29 HCA Inc. ... 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ... , Revenues increased 7.2 percent to $7.483 ... $282 million, compared to $141 million in the prior year,s second quarter. , ...
... ... first of its kind in the world , ... Clifton, NJ (PRWEB) July 28, 2009 -- Announcing the first HelpDesk for ... ,Proper clinical research is the only means to bring modern science and technology to diseased ...
... ... training program designed to help medical transcriptionists prepare to take the Registered Medical Transcriptionist ... ... leading online healthcare education company, has released a new online training program designed to ...
... ... the current economy: Vast amounts of vacancies and subleases are driving down initial rents ... ... International Tenant Representative Alliance , the current downturn in the economy provides a ...
... , , , ... more than 49,000 viewers, Family Research Council Action President Tony ... in five key states including Pennsylvania, Arkansas, Alaska, Louisiana, and Nebraska. ... Obama,s plan become reality - rationing and taxpayer funded abortions. ...
... , , EXTON, Pa., July 28 ... report assessing awareness of the Centers for Medicare and ... Medical Directors and Renal Administrators in dialysis units across ... affiliated with large dialysis chains (i.e. Fresenius, DaVita, DCI) ...
Cached Medicine News:Health News:HCA Reports Second Quarter 2009 Results 2Health News:HCA Reports Second Quarter 2009 Results 3Health News:HCA Reports Second Quarter 2009 Results 4Health News:HCA Reports Second Quarter 2009 Results 5Health News:HCA Reports Second Quarter 2009 Results 6Health News:HCA Reports Second Quarter 2009 Results 7Health News:HCA Reports Second Quarter 2009 Results 8Health News:HCA Reports Second Quarter 2009 Results 9Health News:HCA Reports Second Quarter 2009 Results 10Health News:HCA Reports Second Quarter 2009 Results 11Health News:HCA Reports Second Quarter 2009 Results 12Health News:HCA Reports Second Quarter 2009 Results 13Health News:HCA Reports Second Quarter 2009 Results 14Health News:Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 3Health News:FRC Action Launches TV Ad Campaign On Government Health Care Takeover 2Health News:New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011 2
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
... truly lateral, all quartz fiber. The design ... technology for Total Internal Reflection (TIR) at ... output is virtually indistinguishable from an axial ... in a round spot of low divergence. ...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: